Liver Transplantation

Liver transplant indications, allocation and outcomes are evolving with MELD 3.0, machine perfusion and emerging donor expansion. The session covers MELD 3.0 with female-equity adjustments, donation after circulatory death (DCD) expansion, alcohol-associated liver disease transplant with shortened sobriety requirements, NASH-related transplant trends now the leading indication, machine perfusion (normothermic, hypothermic, ex-vivo systems), and post-transplant immunosuppression optimisation. Discussion addresses living-donor liver transplantation expansion, paediatric liver transplantation, ABO-incompatible transplant, the AOM and ELITA registries, hepatocellular carcinoma transplant criteria (Milan, UCSF, MELD exception), and emerging xenotransplantation programmes including porcine-liver perfusion bridging.